Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 7.70 2.26% 0.17
KALA closed up 2.26 percent on Monday, March 18, 2024, on 85 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction 2.26%
BB Squeeze Started Range Contraction 2.26%
Gapped Down Weakness 2.26%
1,2,3 Pullback Bullish Bullish Swing Setup 0.92%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 15 hours ago
Rose Above Upper Bollinger Band about 16 hours ago
Up 5% about 16 hours ago
Up 1 ATR about 16 hours ago
Rose Above Previous Day's High about 16 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Organ Systems Eye Inflammation Ophthalmic Macular Degeneration Tyrosine Kinase Retina Wet Age Related Macular Degeneration Glucocorticoids Receptor Tyrosine Kinase Retinal Disease Blepharitis Post Surgical Ocular Inflammation

Is KALA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.5699
52 Week Low 5.1
Average Volume 31,811
200-Day Moving Average 9.89
50-Day Moving Average 7.38
20-Day Moving Average 7.44
10-Day Moving Average 7.57
Average True Range 0.38
RSI (14) 55.75
ADX 38.04
+DI 28.51
-DI 7.83
Chandelier Exit (Long, 3 ATRs) 7.10
Chandelier Exit (Short, 3 ATRs) 7.92
Upper Bollinger Bands 7.95
Lower Bollinger Band 6.93
Percent B (%b) 0.76
BandWidth 13.59
MACD Line 0.11
MACD Signal Line 0.09
MACD Histogram 0.0233
Fundamentals Value
Market Cap 20.74 Million
Num Shares 2.69 Million
EPS -22.38
Price-to-Earnings (P/E) Ratio -0.34
Price-to-Sales 1.16
Price-to-Book 1.77
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.27
Resistance 3 (R3) 8.31 8.16 8.18
Resistance 2 (R2) 8.16 8.01 8.14 8.15
Resistance 1 (R1) 7.93 7.92 8.04 7.89 8.12
Pivot Point 7.77 7.77 7.83 7.75 7.77
Support 1 (S1) 7.54 7.63 7.66 7.51 7.28
Support 2 (S2) 7.39 7.54 7.37 7.25
Support 3 (S3) 7.16 7.39 7.22
Support 4 (S4) 7.13